Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-12-003113
Filing Date
2012-08-17
Accepted
2012-08-17 16:59:56
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 585329
2 SECTION 302 CERTIFICATION exhibit31-1.htm EX-31.1 7114
3 SECTION 906 CERTIFICATION exhibit32-1.htm EX-32.1 2577
  Complete submission text file 0001062993-12-003113.txt   9213653

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20120630.xml EX-101.INS 646033
5 XBRL SCHEMA FILE avxl-20120630.xsd EX-101.SCH 276068
6 XBRL CALCULATION FILE avxl-20120630_cal.xml EX-101.CAL 48592
7 XBRL DEFINITION FILE avxl-20120630_def.xml EX-101.DEF 888514
8 XBRL LABEL FILE avxl-20120630_lab.xml EX-101.LAB 2045641
9 XBRL PRESENTATION FILE avxl-20120630_pre.xml EX-101.PRE 948096
Mailing Address 1600 ? 609 GRANVILLE STREET VANCOUVER A1 V7Y 1C3
Business Address 1600 ? 609 GRANVILLE STREET VANCOUVER A1 V7Y 1C3 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-51652 | Film No.: 121043131
SIC: 8731 Services-Commercial Physical & Biological Research